Liver cancer most often kills by destroying enough liver tissue that the organ can no longer perform its essential functions: filtering toxins, producing clotting factors, and regulating dozens of metabolic processes the body depends on to survive. About 62% to 74% of deaths in liver cancer patients are directly caused by the cancer itself, while the remainder result from complications of the underlying liver disease or other organ failure. The specific chain of events varies from person to person, but a handful of well-understood mechanisms account for most deaths.
Liver Failure and Toxic Buildup
The liver filters waste products from the blood, and ammonia is one of the most dangerous. When a tumor replaces or compresses enough healthy liver tissue, ammonia levels rise sharply because the organ can no longer break it down. That ammonia crosses into the brain, where it gets converted into a compound that pulls water into brain cells, causing them to swell. This process, called hepatic encephalopathy, typically unfolds in stages: mild confusion and disorientation at first, then tremors, difficulty with coordination, and eventually seizures, coma, and brain herniation.
In acute liver failure, this progression can happen within days. In patients with slower-growing tumors on a background of cirrhosis, it may develop over weeks, with periods of relative clarity between episodes of confusion. The loss of consciousness in the final stage is not painful in itself, and most patients are unaware of their surroundings by this point.
Internal Bleeding
Liver cancer commonly develops alongside cirrhosis, which raises blood pressure in the portal vein, the major vessel feeding the liver. That increased pressure forces blood into fragile bypass veins, particularly in the esophagus and stomach. These swollen veins, called varices, can rupture without warning, causing massive internal bleeding.
In one study of liver cancer patients who experienced variceal bleeding, the most common cause of death was the hemorrhage itself, accounting for 36% of deaths in that group. The six-week mortality rate after a bleeding episode was 26.4% for liver cancer patients, nearly double the rate seen in patients without cancer. The liver’s inability to produce clotting factors makes the bleeding especially difficult to control, creating a dangerous feedback loop: the worse the liver functions, the harder it is to stop the blood loss.
Kidney Failure
As cirrhosis worsens, it triggers a cascade of circulatory changes that starve the kidneys of blood flow. The failing liver causes blood vessels in the abdomen to widen, which drops overall blood pressure. The body compensates by constricting blood vessels elsewhere, and the kidneys bear the brunt. This condition, hepatorenal syndrome, carries a three-month mortality rate of roughly 90%.
Risk factors that can trigger it include large-volume fluid drainage from the abdomen and infection. Once the kidneys shut down, waste products accumulate in the blood, fluid balance becomes impossible to maintain, and the body’s chemistry deteriorates rapidly.
Infection and Sepsis
Liver cancer suppresses the immune system in multiple ways. The tumor itself creates an environment that exhausts immune cells, particularly the T cells responsible for fighting infection. On top of that, the failing liver produces fewer immune proteins, and many patients are already weakened by cirrhosis, poor nutrition, and the effects of treatment.
This leaves patients highly vulnerable to bacterial infections, which can escalate to sepsis. During sepsis, the body’s inflammatory response spirals out of control, shutting down organs one by one. The combination of an already failing liver, compromised immunity, and widespread inflammation can make even a routine infection fatal. Sepsis also accelerates tumor progression by further suppressing whatever immune function remains.
Fluid Buildup and Breathing Difficulty
Portal hypertension and low protein levels cause fluid to leak into the abdominal cavity, a condition known as ascites. In advanced cases, the abdomen can fill with liters of fluid, pushing upward against the diaphragm and compressing the lungs. This alone can make breathing labored and exhausting.
Some patients also develop a separate problem in the lungs. Liver disease triggers the formation of abnormal connections between blood vessels in the lungs, allowing blood to pass through without picking up oxygen. The result is chronic, worsening breathlessness even when the lungs themselves are structurally intact. Combined with the mechanical pressure from abdominal fluid, these changes can leave patients struggling for air in their final weeks.
Survival by Stage
How quickly these processes unfold depends largely on when the cancer is caught. According to data from the National Cancer Institute’s SEER program, only 3.5% of patients with distant (metastatic) liver cancer survive five years. About 21% of liver cancer cases are already metastatic at diagnosis. Patients whose cancer is caught early and treated with surgery or transplant have significantly better outcomes, but for those with advanced disease, the timeline from diagnosis to death is often measured in months.
Patients with alcohol-related liver disease face a particularly complex picture. Even after curative treatment, they are more likely to die from non-cancer causes like cardiovascular disease, injuries, and complications of cirrhosis than from the cancer recurring.
What the Final Days Look Like
In the last 48 to 72 hours, most patients lose consciousness gradually. Sleeping increases over days or weeks, and periods of confusion become longer. Some patients experience restlessness or agitation, picking at their bedding or talking about things that aren’t happening around them. A brief window of mental clarity sometimes occurs before a final decline into unresponsiveness.
Breathing patterns change noticeably. Breaths may speed up, then slow down, with pauses lasting up to 30 seconds between them. A rattling or gurgling sound from mucus in the throat is common and, while distressing to hear, is not thought to cause the patient discomfort. The skin on the hands, feet, and legs often darkens or takes on a mottled, blotchy appearance as circulation withdraws to the core organs. In liver cancer patients, deepening jaundice (yellowing of the skin and eyes) is typical as bilirubin accumulates.
Pain management during this phase focuses on keeping the patient comfortable. Regular pain medication, repositioning, and sometimes supplemental oxygen or a humidifier can ease breathing. If agitation develops, there are medications available to help. Palliative care teams specialize in managing these symptoms and can adjust treatment as needs change hour to hour. Most patients in the final hours are no longer aware of their surroundings and are not experiencing suffering in any way they can perceive.